Your browser doesn't support javascript.
loading
Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System.
Omidvar, Nader; Tekin, Nilgun; Conget, Paulette; Bruna, Flavia; Timar, Botond; Gagyi, Eva; Basak, Ranjan; Auewarakul, Chirayu; Sritana, Narongrit; Cerci, Juliano Julio; Dimamay, Mark Pierre; Gyorke, Tamas; Redondo, Francisca; Nair, Reena; Gorospe, Charity; Paez, Diana; Fanti, Stefano; Ozdag, Hilal; Padua, Rose Ann; Carr, Robert.
Afiliación
  • Omidvar N; Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom, omidvarn@cf.ac.uk.
  • Tekin N; Biotechnology Institute, Ankara University, Ankara, Turkey.
  • Conget P; Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Bruna F; Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Timar B; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Gagyi E; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Basak R; Department of Medical Oncology and Pathology, Tata Memorial Hospital, Mumbai, India.
  • Auewarakul C; Chulabhorn Cancer Centre and Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.
  • Sritana N; Chulabhorn Cancer Centre and Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.
  • Cerci JJ; Department of Nuclear Medicine, Quanta - Diagnóstico e Terapia, Curitiba, Brazil.
  • Dimamay MP; Research and Biotechnology Division, St Luke's Medical Center, Manila, Philippines.
  • Gyorke T; Department of Nuclear Medicine, Semmelweis University, Budapest, Hungary.
  • Redondo F; Oncologic Clinic, Fundacion Arturo Lopez Perez, Santiago, Chile.
  • Nair R; Department of Medical Oncology and Pathology, Tata Memorial Hospital, Mumbai, India.
  • Gorospe C; Research and Biotechnology Division, St Luke's Medical Center, Manila, Philippines.
  • Paez D; Department of Nuclear Sciences and Application, International Atomic Energy Agency, Vienna, Austria.
  • Fanti S; Metropolitan Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy.
  • Ozdag H; Biotechnology Institute, Ankara University, Ankara, Turkey.
  • Padua RA; INSERM 1131, Université Paris-Diderot, Paris, France.
  • Carr R; Department of Haematology, Guy's and St. Thomas' Hospital, London, United Kingdom.
Acta Haematol ; 143(6): 600-602, 2020.
Article en En | MEDLINE | ID: mdl-32187599
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Proteínas Proto-Oncogénicas / Proteínas Adaptadoras Transductoras de Señales / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Proteínas con Dominio LIM / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Haematol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Proteínas Proto-Oncogénicas / Proteínas Adaptadoras Transductoras de Señales / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Proteínas con Dominio LIM / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Haematol Año: 2020 Tipo del documento: Article